The following information was accurate at the time of posting, but may be superceded by subsequent disclosure.
December 21, 2005
Inex Receives Notice from Majority Note Holder
December 19, 2005
Inex Receives Letter from Majority Note Holder
December 06, 2005
INEX Appoints President & CEO and Updates Reorganization Timetable
November 22, 2005
INEX Receives Feedback from Health Canada on Marqibo™
November 17, 2005
Inex Pharmaceuticals Conference Call Notification
November 17, 2005
INEX to Spin Off Targeted Immunotherapy Assets
November 10, 2005
INEX Q3 2005 Operating Results
November 08, 2005
Inex Receives Notice of Appeal from Note Holder
October 27, 2005
Inex Pharmaceuticals Receives Positive Court Outcome
October 12, 2005
Inex Pharmaceuticals Hearing Completed
September 28, 2005
Inex Pharmaceuticals Receives Notice from Majority Note Holder
September 19, 2005
Inex Receives Letter from Majority Note Holder
August 11, 2005
INEX Releases Second Quarter Results
June 21, 2005
INEX Announces Restructuring Plan and Appoints New President and COO
May 17, 2005
INEX Presents Marqibo Data at Medical Meetings
May 11, 2005
INEX Releases First Quarter 2005 Results
May 04, 2005
INEX AGM Webcast & First Quarter Conference Call
March 17, 2005
INEX Releases 2004 Operating Results & 2005 Milestones
March 17, 2005
Enzon Terminates Marqibo Agreement
March 14, 2005
Conference Call Notification
January 19, 2005
FDA Issues Not Approvable Letter for Marqibo™
